International market share is only 5%. Internationalization of Chinese traditional medicine industry needs to be speeded up

In recent years, the world has set off a "return to nature" green consumption boom, the demand for Chinese herbal medicines in the international market has risen sharply With the increasing recognition of traditional Chinese medicine in the world, the industry of traditional Chinese medicine has also ushered in new opportunities for development However, the industry insiders pointed out that the problems such as low level of industrial modernization, scattered resource allocation, lack of standard system and backward marketing mode seriously restricted the international development of China's traditional Chinese medicine industry, making it difficult to truly and comprehensively go out of the country and into the world Why does the big country of Chinese herbal medicine "marry for others"? Relevant data show that at present, 12807 kinds of traditional Chinese medicine resources have been found and proved in China, with the most abundant natural medicine resources in the world However, the advantage of abundant resources has not really changed into the advantage of industry and market, most of which are cheap exports for others It is understood that at present, the annual sales volume of the world's proprietary Chinese medicine market has reached more than 30 billion US dollars, while China, which has the absolute advantage of Chinese medicine resources in the world, only accounts for 5% of the share According to the national pharmaceutical foreign trade situation conference held recently, at present, the annual scale of China's traditional Chinese medicine industry has reached more than 410 billion yuan, but the export of traditional Chinese medicine products in 2012 was only 2.499 billion US dollars From the perspective of sub projects, the export of traditional Chinese medicine and decoction pieces is $858 million, the export of traditional Chinese medicine is only $265 million, and the export of extract is $1164 million The international export of Chinese patent medicine is still facing difficulties, and there is a deficit of 3 million US dollars again How to find a new way to export Chinese patent medicine has become a problem to be solved in the industry At present, South Korea, Japan, the United States and other countries have directly monopolized about 90% of the international market share of Chinese patent medicine, especially Japan and South Korea, which import raw materials of crude Chinese medicine from China in large quantities to be refined into Chinese patent medicine However, a considerable part of China's export share of less than 5% is created by selling raw materials and low-end products of traditional Chinese medicine, and only 25% of Chinese patent medicines have high added value For example, Korean ginseng, which is widely used in the U.S market, is mostly produced in China Although ginkgo preparations with high price in the domestic market are produced in Japan, Japanese enterprises import them from China at a very low price Dried ginkgo leaves are made and sold again In fact, the main reasons that hinder the export of Chinese patent medicine in China are that the "foreign traditional Chinese medicine" is anti eating the Chinese market, but the transformation ability is poor, the content of science and technology is low, the standard system is missing, the processing method is backward, and the harmful residue exceeds the standard.